AS
IDXX icon

Arxis Securities’s Idexx Laboratories IDXX Stock Holding History

Arxis Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$240K Sell
1,550
-292
-16% -$40.3K 1.28% 29
2016
Q4 		$216K Buy
+1,842
New +$210K 0.3% 28

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arxis Securities's IDXX Position: Q1 2017 in Review

Arxis Securities reduced its Idexx Laboratories (IDXX) stake by 16% in Q1 2017, selling an estimated $40.3K and leaving 1,550 shares worth $240K. The position accounts for 1.28% of the portfolio, ranked #29.

Arxis Securities first reported a position in IDXX in Q4 2016 and has held it in 2 quarters since. 541 funds tracked by Wall St. Rank hold IDXX as of Q1 2017.

  • Arxis Securities held 1,550 shares of Idexx Laboratories worth $240K as of Q1 2017.
  • Arxis Securities sold 292 Idexx Laboratories shares in Q1 2017, an estimated $40.3K.
  • Idexx Laboratories made up 1.28% of Arxis Securities's portfolio in Q1 2017, its #29 holding.
  • Arxis Securities first reported a position in Idexx Laboratories in Q4 2016 and has held it in 2 quarters since.
  • 541 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2017.

Based on Arxis Securities's 13F filing for Q1 2017, filed 8 May 2017.